We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multiplexed Molecular Assays Developed for Foodborne Pathogens

By LabMedica International staff writers
Posted on 11 Jun 2012
Seegene Inc., (Seoul, Korea) and DuPont Nutrition and Health (Wilmington, DE, USA) have agreed to jointly develop highly multiplexed assays for the detection of foodborne pathogens.

Seegene is a leading developer of multiplex molecular technologies and diagnostic tests (M-MoDx) and DuPont Nutrition and Health is a leading provider of rapid, molecular diagnostic systems. More...


The novel technologies from Seegene will be combined with the powerful chemistry and analytics of the BAX System from DuPont, which allows for a potential step-change in pathogen testing. The Seegene Dual Priming Oligonucleotide (DPO) technology generates consistently high specificity by eliminating primer competition, and TOCE technology allows the identification of multiple targets in a single dye channel.

The automated BAX system uses leading-edge technology, including polymerase chain reaction (PCR) assays, tableted reagents and optimized media to detect bacteria and other microbes with certainty. Pathogenic organisms, such as Salmonella, Listeria species, pathogenic Escherichia coli, Shiga toxin-producing E. coli (STEC), Campylobacter, Staphylococcus aureus, Vibrio, and yeast, can be assayed at the genetic level, using the power of the PCR.

The DPO technology is a fundamental tool for blocking extension of nonspecifically primed templates, generating assays that are both highly specific and highly sensitive. The TOCE technology enables simultaneous multiplex testing, by using the differences in melting temperatures of designed artificial amplicons. Prior to TOCE, multiplex assays were difficult because even a small variation in amplicon sequences changes the melting temperature (Tm) of the amplicon. TOCE technology overcomes current limitations of Tm analysis and allows testing of multiple targets with one fluorescent label by ensuring that sequence variation does not change the melting temperature.

Seegene's M-MoDx can simultaneously detect multiple targets with high sensitivity, specificity, and reproducibility. These products detect multipathogens with great reliability and throughput, ultimately providing the most economical basis for saving time, labor, and costs. Jong-Yoon Chun, PhD, founder and chief executive officer of Seegene, said, "By leveraging these novel technologies, we can advance from the current ‘one test, one pathogen’ approach to a ‘one test, many pathogens’ paradigm. This will significantly improve the efficiency and effectiveness of food safety testing, and help to reduce the prevalence of foodborne illness." The combined technologies may have application for both the Public Health laboratories and nosocomial tracing departments.

Related Links:

Seegene Inc.
DuPont Nutrition and Health



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.